The number of contacts with the ombudsman increased 11 percent from 2010 and nearly doubled from the 250 inquiries made in 2009. Nearly two-thirds of the contacts came from within the industry with others coming from consumers (23 percent), healthcare providers (7 percent) and internal employees (5 percent).
Related Articles on the FDA:
FDA Announces 2012 Medical Device Strategic Priorities
FDA Approves Genzyme Framingham Manufacturing Plant
FDA Clears Medtronic’s Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
